For example, miR-125a has been shown to target the ErbB pathway in acute myeloid leukemia cells (Ufkin et al. 2014), and miR-10a has been linked to cell proliferation control via targeting of the PI3 kinase pathway (Hu et al. 2014). This evidence concerns the gene EGFR and acute myeloid leukemia.